1st Edition

Advances in Chromatographic Techniques for Therapeutic Drug Monitoring

Edited By Amitava Dasgupta Copyright 2010
    475 Pages 92 B/W Illustrations
    by CRC Press

    476 Pages 92 B/W Illustrations
    by CRC Press

    For drugs with a narrow therapeutic index, therapeutic drug monitoring methods are essential for patient management. Although immunoassays are commercially available for many drugs and most laboratories use these assays for routine therapeutic monitoring, they have many limitations which hinder their efficacy. Providing practical guidelines for implementing preferred gas and liquid chromatographic methods, Advances in Chromatographic Techniques for Therapeutic Drug Monitoring is a comprehensive reference describing the theory and application of therapeutic drug monitoring in clinical laboratories.

    Edited by a distinguished authority in the field and containing contributions from a variety of experts, the book discusses preanalytical variables, the pitfalls of immunoassays, tandem mass spectrometry, issues related to pain management and herbal supplements, and therapeutic drug monitoring for a range of medications, including:

    • Anticonvulsants
    • Digitalis
    • Cardioactive drugs
    • Antidepressants
    • Immunosuppressants
    • Anti-cancer drugs
    • Vancomycin and aminoglycosides
    • Antibiotics
    • Antiretroviral drugs
    • Nonnarcotic analgesics
    • Anti-inflammatory drugs

     

    Examing older and newer drugs, the book contains detailed discussions on the rationale for therapeutic drug monitoring of each class of drugs, along with their basic pharmacology and toxicology. An extensive list of references is provided at the end of each chapter so that those interested in implementing a new drug assay can find the most appropriate method for the intended drug.

    Introduction to Therapeutic Drug Monitoring and Chromatography, A. Dasgupta

    Preanalytical Variables and Therapeutic Drug Monitoring, V. Bush

    Immunoassays for Therapeutic Drug Monitoring: Pitfalls and Limitations, P. Datta and A. Dasgupta

    Introduction to Tandem Mass Spectrometry, G. L. Hortin

    Analytical Support of Classical Anticonvulsant Drug Monitoring beyond Immunoassay: Application of Chromatographic Methods, J. Juenke and G. McMillin

    Clinical Practice of Therapeutic Drug Monitoring of New Anticonvulsants, M. D. Krasowski

    Chromatographic Techniques in the Therapeutic Drug Monitoring of New Anticonvulsants, C. L. H. Snozek and L. J. Langman

    Problems with Digoxin Immunoassays, A. Dasgupta

    Liquid Chromatography Combined with Immunoassay as a Reference Method for Analysis of Digitalis, E. P. Womack, R. Valdes, and S. A. Jortani

    Chromatographic Methods for Analysis of Cardioactive Drugs, R. W. McLawhon

    Immunoassays for Tricyclic Antidepressants: Unsuitable for Therapeutic Drug Monitoring?, M. D. Krasowski, M. G. Siam, and S. Ekins

    Chromatographic Techniques for the Analysis of Antidepressants, U. Garg

    Pharmacokinetics and Therapeutic Drug Monitoring of Immunosuppressants, K. A. Kelly and A. W. Butch

    Analysis of Immunosuppressants by Liquid Chromatography or Liquid Chromatography with Mass Spectrometry, K. N. Eaton

    Therapeutic Drug Monitoring in Cancer Patients: Application of Chromatographic Techniques, A. Dasgupta

    Therapeutic Drug Monitoring of Vancomycin and Aminoglycosides with Guidelines, R. Dean and A. Dasgupta

    Chromatographic Methods for Analysis of Antibiotics, R. W. McLawhon

    Need for Therapeutic Drug Monitoring of Antiretroviral Medications in HIV Infection, N. Y. Rakhmanina and J. N. van den Anker

    Chromatographic Techniques for Therapeutic Drug Monitoring of Antiretroviral Drugs, A. Dasgupta

    Chromatography in Therapeutic Drug Monitoring of Nonnarcotic Analgesics and Anti-inflammatory Drugs, U. Garg

    Therapeutic Drug Monitoring in Pain Management: Application of Chromatography and Mass Spectrometry, C. L. H. Snozek and L. J. Langman

    Investigation of Drug–herb Interactions: Application of various Chromatographic Techniques for Analysis of Active Components of Herbal Supplements, A. Dasgupta

    Biography

    Dr. Amitava Dasgupta is a Professor of Pathology and Laboratory Medicine at the University of Texas Health Sciences Center at Houston. He is also the Director of Clinical Chemistry, Toxicology, and Point of Care Services at the Memorial-Hermann Hospital Laboratories at the University of Texas Medical School at Houston. He received his PhD in chemistry from Stanford University and completed his fellowship in clinical chemistry from the University of Washington at Seattle. He is certified in both clinical chemistry and toxicology by the American Board of Clinical Chemistry. Dr. Dasgupta’s major research interest is in the field of therapeutic drug monitoring and he has published 175 papers and numerous reviews and has edited four books. He is on the editorial board of American Journal of Clinical Pathology, Archives of Pathology and Laboratory Medicine, Therapeutic Drug Monitoring, Clinica Chimica Acta, and Journal of Clinical Laboratory Analysis.

    …This excellent book reviews not only those drugs for which chromatographic techniques have long been used, but also drugs for which therapeutic monitoring is newer (e.g., antiretroviral agents, immunosuppressive drugs, antineoplastic compounds, antidepressant drugs, analgesics, cardioactive drugs, and antibiotics). … Edited by a distinguished authority on therapeutic drug monitoring, this book should serve as both an invaluable reference for analytical toxicologists and a practical guide for laboratory physicians and scientists who are involved in the monitoring of therapeutic agents.
    —From the Foreword, David N. Bailey, Vice Chancellor for Health Affairs, Dean of the School of Medicine, and Professor of Pathology & Laboratory Medicine, University of California, Irvine, USA

    … a valuable reference for experienced clinical laboratory professionals, as well as an opportunity to inform a new generation of scientists and clinicians of the future potential and growing importance of clinical TDM.
    —Michael Hodsdon in Future Science, May 2010, vol. 2, no. 5